Thank you, Community Fundraisers!
A shout out to all our wonderful community fundraisers, who have supported MIA in the last two months.
Personalised Immunotherapy Platform (PIP)
PIP is a tool developed by MIA to ensure advanced melanoma patients receive effective treatment the first time, based on their own genetics and tumour biology.
Join in Melanoma March 2023 and support Aussies impacted by melanoma
Melanoma March events across the country to fund ground-breaking clinical trial into psychological stresses experienced by advanced melanoma patients.
ABC-X Clinical Trial
The ABC-X clinical trial seeks to determine if the addition of radiotherapy, to combination immunotherapy, results in improved outcomes for patients with melanoma brain metastases.